- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Allergy
Volume 2012 (2012), Article ID 790910, 5 pages
Induction of Specific Immunotherapy with Hymenoptera Venoms Using Ultrarush Regimen in Children: Safety and Tolerance
1Christine Kühne-Center for Allergy Research and Education, University Children's Hospital Zurich, Steinwiesstraße 75, 8032 Zurich, Switzerland
2Children's Allergy and Asthma Hospital, Hochgebirgsklinik Davos, 7265 Davos, Switzerland
Received 14 April 2011; Accepted 16 June 2011
Academic Editor: Mary Beth Hogan
Copyright © 2012 Alice Köhli-Wiesner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- W. Strupler, B. Wuthrich, and C. Schindler, “Prevalence of insect venom allergy in Switzerland: a population study of the SAPALDIA sample,” Allergo Journal, vol. 6, no. 1, pp. S7–S11, 1997.
- R. N. Ross, H. S. Nelson, and I. Finegold, “Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: a meta-analysis,” Clinical Therapeutics, vol. 22, no. 3, pp. 351–358, 2000.
- D. B. K. Golden, “Insect sting allergy and venom immunotherapy,” Annals of Allergy, Asthma and Immunology, vol. 96, supplement 2, pp. S16–S21, 2006.
- U. Müller and H. Mosbech, “Position paper—immunotherapy with hymenoptera venoms. EAACI subcommittee on insect venom allergy,” Allergy, vol. 48, supplement 14, pp. 36–46, 1993.
- J. Birnbaum, D. Charpin, and D. Vervloet, “Rapid hymenoptera venom immunotherapy: comparative safety of three protocols,” Clinical and Experimental Allergy, vol. 23, no. 3, pp. 226–230, 1993.
- F. Bonifazi, M. Jutel, B. M. Bilo, J. Birnbaum, U. Müller, and The EAACI Interest Group on Insect Venom Hypersensitivity, “Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice,” Allergy, vol. 60, pp. 1459–1470, 2005.
- A. Roll, G. Hofbauer, B. K. Ballmer-Weber, and P. Schmid-Grendelmeier, “Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy,” Journal of Investigational Allergology and Clinical Immunology, vol. 16, no. 2, pp. 79–85, 2006.
- J. C. Van der Zwan, J. Flinterman, I. G. Jankowski, and J. A. M. Kerckhaert, “Hyposensitisation to wasp venom in six hours,” British Medical Journal, vol. 287, no. 6402, pp. 1329–1331, 1983.
- D. Schiavino, E. Nucera, E. Pollastrini et al., “Specific ultrarush desensitization in Hymenoptera venom-allergic patients,” Annals of Allergy, Asthma and Immunology, vol. 92, no. 4, pp. 409–413, 2004.
- L. Cox, D. Larenas-Linnemann, R. F. Lockey, and G. Passalacqua, “Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System,” Journal of Allergy and Clinical Immunology, vol. 125, no. 3, pp. 569–e7, 2010.
- H. L. Mueller, “Diagnosis and treatment of insect sensitivity,” The Journal of Asthma Research, vol. 3, no. 4, pp. 331–333, 1966.
- A. Reimers, Y. Hari, and U. Müller, “Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial,” Allergy, vol. 55, no. 5, pp. 484–488, 2000.
- U. Müller, Y. Hari, and E. Berchtold, “Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 107, no. 1, pp. 81–86, 2001.
- P. Johansen, G. Senti, J. Maria Martínez Gómez, and T. M. Kündig, “Medication with antihistamines impairs allergen-specific immunotherapy in mice,” Clinical and Experimental Allergy, vol. 38, no. 3, pp. 512–519, 2008.
- L. J. F. Youlten, B. A. Atkinson, and T. H. Lee, “The incidence and nature of adverse reactions to injection immunotherapy in bee and wasp venom allergy,” Clinical and Experimental Allergy, vol. 25, no. 2, pp. 159–165, 1995.
- J. Birnbaum, M. Ramadour, A. Magnan, and D. Vervloet, “Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors,” Clinical and Experimental Allergy, vol. 33, no. 1, pp. 58–64, 2003.
- H. Mosbech and U. Muller, “Side-effects of insect venom immunotherapy: results from an EAACI multicenter study,” Allergy, vol. 55, no. 11, pp. 1005–1010, 2000.
- J. Wenzel, M. Meissner-Kraemer, R. Bauer, T. Bieber, and R. Gerdsen, “Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients,” Allergy, vol. 58, no. 11, pp. 1176–1179, 2003.
- R. Brehler, H. Wolf, B. Kütting, J. Schnitker, and T. Luger, “Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections,” Journal of Allergy and Clinical Immunology, vol. 105, no. 6, pp. 1231–1235, 2000.
- J. Laurent, J. M. Smiejan, E. Bloch-Morot, and D. Herman, “Safety of Hymenoptera venom rush immunotherapy,” Allergy, vol. 52, no. 1, pp. 94–96, 1997.